Literature DB >> 25975733

No effect of basic bladder advice in enuresis: A randomized controlled trial.

Maria Cederblad1, Anna Sarkadi2, Gunn Engvall3, Tryggve Nevéus2.   

Abstract

BACKGROUND: There are two firstline, evidence-based treatments available for nocturnal enuresis: desmopressin and the enuresis alarm. Prior to use of these therapies, international experts usually recommend that the children also be given basic bladder training during the daytime. The rationale behind this recommendation is that daytime bladder training or urotherapy, is a mainstay in the treatment of daytime incontinence caused by detrusor overactivity. Still, there is, as yet, no firm evidence that daytime bladder training is useful against nocturnal enuresis. AIM: To explore whether basic bladder advice has any effect against nocturnal enuresis. STUDY
DESIGN: The study was prospective, randomized, and controlled. The evaluated intervention was bladder advice, given in accordance with ICCS guidelines and focused on regular voiding, sound voiding posture, and sufficient fluid intake. Forty children aged 6 years or more with previously untreated enuresis, but no daytime incontinence, were randomized (20 in each group) to receive either first basic bladder advice for 1 month and then alarm therapy (group A) or just the alarm therapy (group B). Based on power calculations, the minimum number of children required in each treatment arm was 15.
RESULTS: The basic bladder advice did not reduce the enuresis frequency in group A (p = 0.089) and the end result after alarm therapy did not differ between the two groups (p = 0.74) (see Table). Only four children in group A had a partial or full response to bladder training, and two of these children relapsed immediately during alarm therapy. DISCUSSION: This was the first study to evaluate, in a prospective, randomized manner, the value of daytime basic bladder training as a treatment of enuresis. It was found that the treatment neither resulted in a significant reduction in the number of wet nights, nor did it improve the success of subsequent alarm therapy.
CONCLUSIONS: The recommendation that all children with enuresis be given bladder training as a firstline therapy can no longer be supported. Instead, we recommend that treatment of these children start with the enuresis alarm or desmopressin without delay.
Copyright © 2015 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  After treatment; Children; Nocturnal enuresis; Nursing; Primary care

Mesh:

Year:  2015        PMID: 25975733     DOI: 10.1016/j.jpurol.2015.03.004

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  5 in total

1.  A new checklist method enhances treatment compliance and response of behavioural therapy for primary monosymptomatic nocturnal enuresis: a prospective randomised controlled trial.

Authors:  Ahmet Metin Hascicek; Muhammet Fatih Kilinc; Yildiray Yildiz; Cem Nedim Yuceturk; Omer Gokhan Doluoglu
Journal:  World J Urol       Date:  2018-09-06       Impact factor: 4.226

Review 2.  An interprofessional approach to managing children with treatment-resistant enuresis: an educational review.

Authors:  Patrina H Y Caldwell; Melissa Lim; Gail Nankivell
Journal:  Pediatr Nephrol       Date:  2017-11-06       Impact factor: 3.714

3.  Alarm interventions for nocturnal enuresis in children.

Authors:  Patrina Hy Caldwell; Miriam Codarini; Fiona Stewart; Deirdre Hahn; Premala Sureshkumar
Journal:  Cochrane Database Syst Rev       Date:  2020-05-04

4.  Daytime urotherapy in nocturnal enuresis: a randomised, controlled trial.

Authors:  Malin Borgström; Amadeus Bergsten; Maria Tunebjer; Barbro Hedin Skogman; Tryggve Nevéus
Journal:  Arch Dis Child       Date:  2022-01-24       Impact factor: 4.920

5.  Desmopressin plus anticholinergic agent in the treatment of nocturnal enuresis: A meta-analysis.

Authors:  Jianyong Yu; Zhaojun Yan; Shiying Zhou; Feng Han; Feng Xiao; Jian Han; Congling Sun
Journal:  Exp Ther Med       Date:  2017-08-07       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.